The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 6, 2010, Pages 672-678

  Jokela, R ^a   Ahonen, J ^a   Seitsonen, E ^a   Marjakangas, P ^a   Korttila, K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DROPERIDOL; IBUPROFEN; ONDANSETRON; OXYCODONE; PARACETAMOL; PLACEBO;

ADULT; ANALGESIC ACTIVITY; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED HEADACHE; FEMALE; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MENTAL CONCENTRATION; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ACETAMINOPHEN; ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; MIDDLE AGED; ONDANSETRON; OXYCODONE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; SEROTONIN ANTAGONISTS;

EID: 77952583915     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.281     Document Type: Article

References (23)

1. Toes, M.J., Jones, A.L. & Prescott, L. Drug interactions with paracetamol. Am. J. Ther. 12, 56-66 (2005).
2. Pavlicevic, I., Kuzmanic, M., Rumboldt, M. & Rumboldt, Z. Interaction between antihypertensives and NSAIDs in primary care: a controlled trial. Can. J. Clin. Pharmacol. 15, e372-e382 (2008).
3. Pickering, G., Loriot, M.A., Libert, F., Eschalier, A., Beaune, P. & Dubray, C. Analgesic efect of acetaminophen in humans: frst evidence of a central serotonergic mechanism. Clin. Pharmacol. Ther. 79, 371-378 (2006).
4. Pickering, G., Estève, V., Loriot, M.A., Eschalier, A. & Dubray, C. Acetaminophen reinforces descending inhibitory pain pathways. Clin. Pharmacol. Ther. 84, 47-51 (2008).
5. Graham, G.G. & Scott, K.F. Mechanism of action of paracetamol. Am. J. Ther. 12, 46-55 (2005).
6. Tjølsen, A., Lund, A. & Hole, K. Antinociceptive efect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur. J. Pharmacol. 193, 193-201 (1991).
7. Pelissier, T., Alloui, A., Paeile, C. & Eschalier, A. Evidence of a central antinociceptive efect of paracetamol involving spinal 5HT3 receptors. Neuroreport. 6, 1546-1548 (1995).
8. Bonnefont, J., Courade, J.P., Alloui, A. & Eschalier, A. Antinociceptive mechanism of action of paracetamol. Drugs 63 (Spec No. 2), 1-4 (2003).
9. Bonnefont, J., Chapuy, E., Clottes, E., Alloui, A. & Eschalier, A. Spinal 5-HT1A receptors diferentially infuence nociceptive processing according to the nature of the noxious stimulus in rats: efect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114, 482-490 (2005).
10. Zhang, Y.Q., Gao, X., Zhang, L.M. & Wu, G.C. The release of serotonin in rat spinal dorsal horn and periaqueductal gray following carrageenan infammation. Neuroreport. 11, 3539-3543 (2000).
11. Libert, F. et al. Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT(3) receptor-mediated efect. Mol. Pharmacol. 66, 728-734 (2004).
12. Bardin, L., Jourdan, D., Alloui, A., Lavarenne, J. & Eschalier, A. Diferential infuence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats. Brain Res. 765, 267-272 (1997).
13. Courade, J.P., Chassaing, C., Bardin, L., Alloui, A. & Eschalier, A. 5-HT receptor subtypes involved in the spinal antinociceptive efect of acetaminophen in rats. Eur. J. Pharmacol. 432, 1-7 (2001).
14. Apfel, C.C. et al.; IMPACT Investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N. Engl. J. Med. 350, 2441-2451 (2004).
15. Blower, P.R. 5-HT3-receptor antagonists and the cytochrome P450 system: clinical implications. Cancer J. 8, 405-414 (2002).
16. U.S. Food and Drug Administration. Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers http://www.fda. gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ DrugInteractionsLabeling/ucm081177.htm. Accessed 9 August 2009.
17. Villikka, K., Kivistö, K.T. & Neuvonen, P.J. The efect of dexamethasone on the pharmacokinetics of triazolam. Pharmacol. Toxicol. 83, 135-138 (1998).
18. McCune, J.S. et al. In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone. Clin. Pharmacol. Ther. 68, 356-366 (2000).
19. Yang, S.H., Suh, J.H. & Lee, M.G. Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2. Cancer Chemother. Pharmacol. 65, 407-418 (2010).
20. Lalovic, B., Phillips, B., Risler, L.L., Howald, W. & Shen, D.D. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab. Dispos. 32, 447-454 (2004).
21. Lalovic, B., Kharasch, E., Hofer, C., Risler, L., Liu-Chen, L.Y. & Shen, D.D. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin. Pharmacol. Ther. 79, 461-479 (2006).
22. Heiskanen, T., Olkkola, K.T. & Kalso, E. Efects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Clin. Pharmacol. Ther. 64, 603-611 (1998).
23. Jokela, R., Ahonen, J., Tallgren, M., Haanpää, M. & Korttila, K. A randomized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy. Pain. 134, 106-112 (2008).